丙型肝炎：临床综述。
Hepatitis C: a clinical review.
作者信息
Modi A A, Liang T J
机构信息
The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
Oral Dis. 2008 Jan;14(1):10-4. doi: 10.1111/j.1601-0825.2007.01419.x.
Abstract
Hepatitis C is a major cause of chronic liver disease. It has been recognized as a global health problem because of the progression to cirrhosis and hepatocellular cancer. Chronic hepatitis C is usually asymptomatic but can cause considerable liver damage before its recognition. This review discusses the natural history, clinical features, diagnosis, therapy, treatment responses and the side effects associated with the treatment of hepatitis C.
摘要
丙型肝炎是慢性肝病的主要病因。由于其会发展为肝硬化和肝细胞癌，已被公认为一个全球性的健康问题。慢性丙型肝炎通常没有症状，但在被发现之前可能会造成相当程度的肝脏损害。本综述讨论了丙型肝炎的自然史、临床特征、诊断、治疗、治疗反应以及与丙型肝炎治疗相关的副作用。
相似文献
1
Hepatitis C: a clinical review.
Oral Dis. 2008 Jan;14(1):10-4. doi: 10.1111/j.1601-0825.2007.01419.x.
2
Universal screening for chronic hepatitis C virus.
Liver Int. 2016 Jan;36 Suppl 1:62-6. doi: 10.1111/liv.13012.
3
Antiviral agents and hepatitis C.
N Y State Dent J. 2012 Jun-Jul;78(4):42-5.
4
Natural history of acute and chronic hepatitis C.
Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):401-12. doi: 10.1016/j.bpg.2012.09.009.
5
Clinical practice. Chronic hepatitis C infection.
N Engl J Med. 2011 Jun 23;364(25):2429-38. doi: 10.1056/NEJMcp1006613.
6
[Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].
Zhonghua Gan Zang Bing Za Zhi. 2018 Mar 20;26(3):175-178. doi: 10.3760/cma.j.issn.1007-3418.2018.03.004.
7
Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.
Semin Liver Dis. 2007 Feb;27(1):13-27. doi: 10.1055/s-2006-960168.
8
Hepatitis C for primary care physicians.
J Am Board Fam Med. 2014 Mar-Apr;27(2):284-91. doi: 10.3122/jabfm.2014.02.130165.
9
Breakthroughs in hepatitis C research: from discovery to cure.
Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):533-550. doi: 10.1038/s41575-022-00608-8. Epub 2022 May 20.
10
Epidemiology and natural history of hepatitis C virus infection among children and young people.
J Hepatol. 2019 Mar;70(3):371-378. doi: 10.1016/j.jhep.2018.11.013. Epub 2018 Nov 27.
引用本文的文献
1
Successes and challenges of best practice alerts to identify and engage individuals living with hepatitis C virus.
Front Public Health. 2024 May 20;12:1281079. doi: 10.3389/fpubh.2024.1281079. eCollection 2024.
2
The effect of first-wave COVID-19 restrictions on HCV testing in Alberta, Canada: A trend analysis from 2019 to 2022.
Can Liver J. 2024 May 8;7(2):273-285. doi: 10.3138/canlivj-2023-0027. eCollection 2024 May.
3
A province-by-province cost-effectiveness analysis and budget impact analysis of one-time birth cohort screening of hepatitis C virus (HCV) infection in Canada.
Sci Rep. 2023 Aug 18;13(1):13484. doi: 10.1038/s41598-023-39521-8.
4
Gastrointestinal tract and viral pathogens.
World J Virol. 2023 Jun 25;12(3):136-150. doi: 10.5501/wjv.v12.i3.136.
5
Performance Comparison of Machine Learning Approaches on Hepatitis C Prediction Employing Data Mining Techniques.
Bioengineering (Basel). 2023 Apr 17;10(4):481. doi: 10.3390/bioengineering10040481.
6
Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors.
Int J Mol Sci. 2022 Nov 6;23(21):13612. doi: 10.3390/ijms232113612.
7
Probing a Stochastic Epidemic Hepatitis C Virus Model with a Chronically Infected Treated Population.
Acta Math Sci. 2022;42(5):2087-2112. doi: 10.1007/s10473-022-0521-1. Epub 2022 Jul 25.
8
Analysis of serum and gene expression profile of cytokines (IL-6, TNF-α and TGF-β1) in chronic hepatitis C virus infection.
PeerJ. 2022 Apr 20;10:e13330. doi: 10.7717/peerj.13330. eCollection 2022.
9
Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations.
Appl Health Econ Health Policy. 2022 Mar;20(2):171-183. doi: 10.1007/s40258-021-00694-w. Epub 2021 Dec 6.
10
Hepatic pathological features in naïve patients with chronic hepatitis C who have developed thyroid disorder.
Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1085-1097. doi: 10.47162/RJME.61.4.11.
本文引用的文献
1
Treatment of hepatitis C: don't put all your eggs in one basket!
Gastroenterology. 2007 Apr;132(4):1611-5. doi: 10.1053/j.gastro.2007.03.014.
2
The economics of hepatitis C virus.
Clin Liver Dis. 2006 Nov;10(4):717-34. doi: 10.1016/j.cld.2006.08.026.
3
Peginterferon and ribavirin for chronic hepatitis C.
N Engl J Med. 2006 Dec 7;355(23):2444-51. doi: 10.1056/NEJMct061675.
4
Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.
Gastroenterology. 2006 Mar;130(3):632-8. doi: 10.1053/j.gastro.2006.01.034.
5
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.
Hepatology. 2006 Feb;43(2):250-6. doi: 10.1002/hep.21043.
6
American Gastroenterological Association technical review on the management of hepatitis C.
Gastroenterology. 2006 Jan;130(1):231-64; quiz 214-7. doi: 10.1053/j.gastro.2005.11.010.
7
Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study.
Am J Gastroenterol. 2005 Nov;100(11):2447-52. doi: 10.1111/j.1572-0241.2005.00253.x.
8
Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
Nature. 2005 Aug 18;436(7053):967-72. doi: 10.1038/nature04082.
9
Unravelling hepatitis C virus replication from genome to function.
Nature. 2005 Aug 18;436(7053):933-8. doi: 10.1038/nature04077.
10
Natural history of hepatitis C.
Clin Liver Dis. 2005 Aug;9(3):383-98, vi. doi: 10.1016/j.cld.2005.05.003.
Zotero 插件